Position in XENE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$17,474,075
+$17,265,295 QoQ
Shares Held
300,500
+5678.8% QoQ
Ownership
0.311%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. XENE ranks #36 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in XENE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,474,075 | 300,500 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $208,780 | 5,200 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $269,180 | 8,600 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,190,185 | 154,700 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $537,040 | 13,700 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,732,280 | 44,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,622,171 | 92,900 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,428,020 | 56,400 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,501,556 | 32,600 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $748,104 | 21,900 | Shares | Sole | 2023-11-14 | |
| 2022-03-31 | $4,609,252 | 150,777 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,898,597 | 380,877 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,459,496 | 619,077 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $12,251,531 | 657,977 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $12,404,288 | 692,977 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $11,842,246 | 769,977 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $9,999,276 | 903,277 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $12,982,373 | 1,035,277 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,936,793 | 788,077 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||